Search

Displaying results 5831 - 5840 of 8009 in total
  1. Drug

    Rugonersen

    go.drugbank.com/drugs/DB18662
    Investigational

    Rugonersen is a locked nucleic acid antisense oligonucleotide under investigation for the treatment of Angelman Syndrome.

  2. Drug

    IMT-288

    go.drugbank.com/drugs/DB19068
    Investigational

    IMT-288 is under investigation in clinical trial NCT01730638 (Immunotep for Patients With Medullary Thyroid Carcinoma.).

  3. Drug

    Ensovibep

    go.drugbank.com/drugs/DB19078
    Investigational

    Ensovibep is under investigation in clinical trial NCT04501978 (ACTIV-3: Therapeutics for Inpatients With COVID-19).

  4. Drug

    123I-iodometomidate

    go.drugbank.com/drugs/DB13021
    Investigational

    123I-iodometomidate is under investigation in clinical trial NCT00454103 (Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy).

  5. Drug

    Icariin

    go.drugbank.com/drugs/DB12052
    Investigational

    Icariin has been investigated for the basic science of the Pharmacokinetic Profile of Icariin in Humans.

  6. Drug

    AB-207

    go.drugbank.com/drugs/DB22801
    Investigational

    AB-207 is under investigation in clinical trial NCT06456073 (E-CEL UVEC Treatment for Anal Fissures).

  7. Drug

    Bryostatin 1

    go.drugbank.com/drugs/DB11752
    Investigational

    Bryostatin 1 has been investigated for the treatment of HIV Infection and Alzheimer's Disease.

  8. Drug

    ALMB-0168

    go.drugbank.com/drugs/DB16926
    Investigational

    ALMB-0168 is a humanized connexin 43 (Cx43) monoclonal antibody being investigated for osteosarcoma.

  9. Drug

    AQ-13

    go.drugbank.com/drugs/DB17749
    Investigational

    AQ-13 is an 4-aminoquinoline analog being investigated for the treatment of malaria.

  10. Drug

    Rotigaptide

    go.drugbank.com/drugs/DB13067
    Investigational

    Rotigaptide is under investigation for the basic science of Heart Disease and Vascular Disease.